Overnight glucose control in people with type 1 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Overnight glucose control in people with type 1 diabetes. / Boiroux, Dimitri; Duun-Henriksen, Anne Katrine; Schmidt, Signe; Nørgaard, Kirsten; Madsbad, Sten; Poulsen, Niels Kjølstad; Madsen, Henrik; Jørgensen, John Bagterp.

In: Biomedical Signal Processing and Control, Vol. 39, 2018, p. 503-512.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Boiroux, D, Duun-Henriksen, AK, Schmidt, S, Nørgaard, K, Madsbad, S, Poulsen, NK, Madsen, H & Jørgensen, JB 2018, 'Overnight glucose control in people with type 1 diabetes', Biomedical Signal Processing and Control, vol. 39, pp. 503-512. https://doi.org/10.1016/j.bspc.2017.08.005

APA

Boiroux, D., Duun-Henriksen, A. K., Schmidt, S., Nørgaard, K., Madsbad, S., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2018). Overnight glucose control in people with type 1 diabetes. Biomedical Signal Processing and Control, 39, 503-512. https://doi.org/10.1016/j.bspc.2017.08.005

Vancouver

Boiroux D, Duun-Henriksen AK, Schmidt S, Nørgaard K, Madsbad S, Poulsen NK et al. Overnight glucose control in people with type 1 diabetes. Biomedical Signal Processing and Control. 2018;39:503-512. https://doi.org/10.1016/j.bspc.2017.08.005

Author

Boiroux, Dimitri ; Duun-Henriksen, Anne Katrine ; Schmidt, Signe ; Nørgaard, Kirsten ; Madsbad, Sten ; Poulsen, Niels Kjølstad ; Madsen, Henrik ; Jørgensen, John Bagterp. / Overnight glucose control in people with type 1 diabetes. In: Biomedical Signal Processing and Control. 2018 ; Vol. 39. pp. 503-512.

Bibtex

@article{e25a447af2ed48bab0d6f0a10c37d2cc,
title = "Overnight glucose control in people with type 1 diabetes",
abstract = "This paper presents an individualized model predictive control (MPC) algorithm for overnight blood glucose stabilization in people with type 1 diabetes (T1D). The MPC formulation uses an asymmetric objective function that penalizes low glucose levels more heavily. We compute the model parameters in the MPC in a systematic way based on a priori available patient information. The model used by the MPC algorithm for filtering and prediction is an autoregressive integrated moving average with exogenous input (ARIMAX) model implemented as a linear state space model in innovation form. The control algorithm uses frequent glucose measurements from a continuous glucose monitor (CGM) and its decisions are implemented by a continuous subcutaneous insulin infusion (CSII) pump. We provide guidelines for tuning the control algorithm and computing the Kalman gain in the linear state space model in innovation form. We test the controller on a cohort of 100 randomly generated virtual patients with a representative inter-subject variability. We use the same control algorithm for a feasibility overnight study using 5 real patients. In this study, we compare the performance of this control algorithm with the patient's usual pump setting. We discuss the results of the numerical simulations and the in vivo clinical study from a control engineering perspective. The results demonstrate that the proposed control strategy increases the time spent in euglycemia.",
author = "Dimitri Boiroux and Duun-Henriksen, {Anne Katrine} and Signe Schmidt and Kirsten N{\o}rgaard and Sten Madsbad and Poulsen, {Niels Kj{\o}lstad} and Henrik Madsen and J{\o}rgensen, {John Bagterp}",
year = "2018",
doi = "10.1016/j.bspc.2017.08.005",
language = "English",
volume = "39",
pages = "503--512",
journal = "Biomedical Signal Processing and Control",
issn = "1746-8094",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Overnight glucose control in people with type 1 diabetes

AU - Boiroux, Dimitri

AU - Duun-Henriksen, Anne Katrine

AU - Schmidt, Signe

AU - Nørgaard, Kirsten

AU - Madsbad, Sten

AU - Poulsen, Niels Kjølstad

AU - Madsen, Henrik

AU - Jørgensen, John Bagterp

PY - 2018

Y1 - 2018

N2 - This paper presents an individualized model predictive control (MPC) algorithm for overnight blood glucose stabilization in people with type 1 diabetes (T1D). The MPC formulation uses an asymmetric objective function that penalizes low glucose levels more heavily. We compute the model parameters in the MPC in a systematic way based on a priori available patient information. The model used by the MPC algorithm for filtering and prediction is an autoregressive integrated moving average with exogenous input (ARIMAX) model implemented as a linear state space model in innovation form. The control algorithm uses frequent glucose measurements from a continuous glucose monitor (CGM) and its decisions are implemented by a continuous subcutaneous insulin infusion (CSII) pump. We provide guidelines for tuning the control algorithm and computing the Kalman gain in the linear state space model in innovation form. We test the controller on a cohort of 100 randomly generated virtual patients with a representative inter-subject variability. We use the same control algorithm for a feasibility overnight study using 5 real patients. In this study, we compare the performance of this control algorithm with the patient's usual pump setting. We discuss the results of the numerical simulations and the in vivo clinical study from a control engineering perspective. The results demonstrate that the proposed control strategy increases the time spent in euglycemia.

AB - This paper presents an individualized model predictive control (MPC) algorithm for overnight blood glucose stabilization in people with type 1 diabetes (T1D). The MPC formulation uses an asymmetric objective function that penalizes low glucose levels more heavily. We compute the model parameters in the MPC in a systematic way based on a priori available patient information. The model used by the MPC algorithm for filtering and prediction is an autoregressive integrated moving average with exogenous input (ARIMAX) model implemented as a linear state space model in innovation form. The control algorithm uses frequent glucose measurements from a continuous glucose monitor (CGM) and its decisions are implemented by a continuous subcutaneous insulin infusion (CSII) pump. We provide guidelines for tuning the control algorithm and computing the Kalman gain in the linear state space model in innovation form. We test the controller on a cohort of 100 randomly generated virtual patients with a representative inter-subject variability. We use the same control algorithm for a feasibility overnight study using 5 real patients. In this study, we compare the performance of this control algorithm with the patient's usual pump setting. We discuss the results of the numerical simulations and the in vivo clinical study from a control engineering perspective. The results demonstrate that the proposed control strategy increases the time spent in euglycemia.

U2 - 10.1016/j.bspc.2017.08.005

DO - 10.1016/j.bspc.2017.08.005

M3 - Journal article

VL - 39

SP - 503

EP - 512

JO - Biomedical Signal Processing and Control

JF - Biomedical Signal Processing and Control

SN - 1746-8094

ER -

ID: 217615965